We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -4.44% | 5.375 | 5.25 | 5.50 | 5.625 | 5.375 | 5.625 | 1,268,205 | 14:37:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -1.20 | 6.18M |
TIDMGDR
RNS Number : 7445Y
Genedrive PLC
07 December 2017
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the near patient molecular diagnostics company, announces that it has granted share options ("Options") to certain of its directors and senior management to acquire a total of 156,087 ordinary shares of 1.5p each in the capital of the Company under the Company's newly adopted 2017 Share Option Scheme.
The Options have been granted with an exercise price equal to the close price on the day before grant and vest after a period of three years. The Options will vest after 3 years only if certain performance criteria are met. The Options are exercisable over the period of 10 years from the date of grant.
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
1. Details of the person discharging managerial responsibilities / person closely associated --- ------------------------------------------------------------------------------- a. Name 1. Gordon Powell 2. Gino Miele 3. Nancy Neilson --- ------------------------------ ----------------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------------------------- a. Position/status 1. Commercial Director 2. R&D Director 3. Quality Assurance Director --- ------------------------------ ----------------------------------------------- a. Initial notification Initial notification /Amendment --- ------------------------------ ----------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------------------------- a. Name genedrive plc --- ------------------------------ ----------------------------------------------- b. LEI 213800ZYODIRZ87Y4K14 --- ------------------------------ ----------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------------------------- a. Description Options over ordinary shares of of the 1.5 pence each Financial instrument, type of instrument Identification code --- ------------------------------ ----------------------------------------------- b. Nature of Grant of options pursuant to and the transaction in accordance with the terms of the Company's Share Option Scheme dated 29 November 2017. --- ------------------------------ ----------------------------------------------- c. Price(s) Price(s) Option Volume(s) and volume(s) price(s) -------------------- ---------- ---------- Gordon Powell 36.0p 88,063 -------------------- ---------- ---------- Gino Miele 36.0p 43,024 -------------------- ---------- ---------- Nancy Neilson 36.0p 25,000 -------------------- ---------- ---------- --- ------------------------------ ----------------------------------------------- d. Aggregated information N/A * Aggregated volume * Price --- ------------------------------ ----------------------------------------------- e. Date of the 2017-12-07; UTC time transaction --- ------------------------------ ----------------------------------------------- f. Place of Outside trading venue - shares the transaction to be admitted to AIM market of London Stock Exchange plc on exercise of options --- ------------------------------ -----------------------------------------------
For further details please contact:
genedrive plc +44 (0)161 989 0245 David Budd: CEO Matthew Fowler: CFO Peel Hunt LLP +44 (0)207 418 8900 James Steel Oliver Jackson Consilium Strategic Communications +44 (0)203 709 5700 Chris Gardner Matthew Neal Laura Thornton genedrive@consilium-comms.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAKAXEAKXFFF
(END) Dow Jones Newswires
December 07, 2017 11:28 ET (16:28 GMT)
1 Year Genedrive Chart |
1 Month Genedrive Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions